Literature DB >> 18220385

Molecular dynamics study to investigate the effect of chemical substitutions of methionine 35 on the secondary structure of the amyloid beta (Abeta(1-42)) monomer in aqueous solution.

Luciano Triguero1, Rajiv Singh, Rajeev Prabhakar.   

Abstract

In this study, all-atom molecular dynamics simulations in the explicit water solvent are performed to investigate conformational changes in the secondary structure of the Abeta(1-42) monomer associated with the substitution of the Cgamma-methylene position of the Met35 amino acid residue by sulfoxide (Met35(O)), sulfone (Met35(O2)), and norleucine (Met35(CH2)). The effects of these substitutions on the structural changes that occur in three distinct regions (the central hydrophobic core (CHC) region 17-21 (LVFFA), stable turn segment 24-27 (VGSN), and second hydrophobic region 29-35 (GAIIGLM)) of all monomers have been analyzed in detail, and results are compared with experiments. Our 20 ns simulations indicate that the most significant changes take place in the second hydrophobic region of the Met35(O) and Met35(O2) monomers. However, for the Met35(CH2) monomer, this region does not exhibit significant deviations. In comparison to the wild-type (WT)-Abeta(1-42) monomer, for Met35(O) the second hydrophobic region is characterized by the formation of internal beta-sheets separated by stable turns, whereas for Met35(O2) it exhibits a more helical conformation. These substantial changes in the secondary structure can be explained in terms of an increase in the computed dipole moment and solvent accessible surface area (SASA) per residue of these substituents. These structural modifications can affect interaction between monomers, which in turn may influence the oligomerization process involved in Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220385     DOI: 10.1021/jp0771872

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  7 in total

1.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

2.  Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation?

Authors:  Andrew Hung; Michael D W Griffin; Geoffrey J Howlett; Irene Yarovsky
Journal:  Eur Biophys J       Date:  2008-09-04       Impact factor: 1.733

3.  Investigation of the effect of erythrosine B on amyloid beta peptide using molecular modeling.

Authors:  Juho Lee; Inchan Kwon; Seung Soon Jang; Art E Cho
Journal:  J Mol Model       Date:  2016-03-28       Impact factor: 1.810

4.  Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion?

Authors:  Yogita Mantri; Marco Fioroni; Mu-Hyun Baik
Journal:  J Biol Inorg Chem       Date:  2008-07-08       Impact factor: 3.358

Review 5.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

6.  Unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations.

Authors:  Mika Ito; Jan Johansson; Roger Strömberg; Lennart Nilsson
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

7.  Effects of ligands on unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations.

Authors:  Mika Ito; Jan Johansson; Roger Strömberg; Lennart Nilsson
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.